How To Molecular Diagnostic Mesothelioma

 How To Molecular Diagnostic Mesothelioma

The recently discovered and naturally occurring microRNAs (miRNAs) act as master regulators and have the potential to form the basis for a new class of diagnostics and therapeutics. Since many diseases are caused by the abnormal activity of proteins, the ability to selectively regulate protein activity through microRNAs could provide the means to treat a wide range of human diseases.

Rosetta Genomics, a Philadelphia-based developer of microRNA-based molecular diagnostic tests, has developed a comprehensive mesothelioma diagnosis exam that is now commercially available. The test is the third microRNA-based diagnostic test created by the lab and is known as miRview™ meso. miRview™ meso differentiates mesothelioma, a cancer connected to asbestos exposure, from other carcinomas in the lung. Currently, there is no single diagnostic test that is entirely conclusive for this differentiation.